Found 16 matching trials
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
PHASE2This is a prospective, single-center, placebo-controlled, non-comparative, ...
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
PHASE2RATIONALE: Zoledronic acid, vitamin D, and calcium may prevent bone loss in...
Location
Masonic Cancer Center at University of Minnesota
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
PHASE4This study will compare the effectiveness of denosumab treatment every 6 mo...
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
PHASE2This is a 4-week study to examine the effects of a new experimental medicat...
Location
Multiple Locations
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
PHASE3Post-menopausal breast cancer patients will receive letrozole 2.5 mg daily ...
Location
Novartis Investigative Site
Zoledronic Acid in MS-patients With Osteoporosis
PHASE3This study is designed to evaluate the efficacy and safety of zoledronic ac...
Location
Novartis Investigative Site
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
PHASE4This study evaluated the effectiveness and safety of a dosing method for zo...
Location
TriValley Cancer Research and Treatment Center
The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer
PHASE4Metastatic breast cancer patients with bone involvement who are at high-ris...
Location
The Ottawa Hospital Cancer Centre
Re-treatment of Participants With Paget's Disease Using Zoledronic Acid
PHASE4The purpose of this study was to demonstrate that participants with Paget's...
Location
Novartis Investigative site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
PHASE3The purpose of this study is to determine if denosumab is non-inferior to z...